Beryl Drugs Ltd recorded two insider trading transactions during the past ninety days, both involving net purchases by Sudhir Sethi. These acquisitions totaled 128,228 INR, representing approximately 0.0017% of the float. The stock price increased 17.4% over this period, while no recent earnings report data is currently available for the firm.